Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1976 1
1977 1
1978 3
1979 1
1980 3
1981 4
1982 4
1983 3
1984 4
1985 4
1986 1
1987 4
1988 6
1989 2
1990 3
1991 1
1992 1
1993 4
1994 3
1995 2
1996 6
1997 2
1998 3
1999 2
2000 4
2002 4
2003 5
2004 1
2005 2
2006 4
2007 10
2008 2
2009 6
2010 8
2011 11
2012 11
2013 7
2014 5
2015 7
2016 11
2017 12
2018 11
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

187 results
Results by year
Filters applied: . Clear all
Page 1
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
Asim M, Tarish F, Zecchini HI, Sanjiv K, Gelali E, Massie CE, Baridi A, Warren AY, Zhao W, Ogris C, McDuffus LA, Mascalchi P, Shaw G, Dev H, Wadhwa K, Wijnhoven P, Forment JV, Lyons SR, Lynch AG, O'Neill C, Zecchini VR, Rennie PS, Baniahmad A, Tavaré S, Mills IG, Galanty Y, Crosetto N, Schultz N, Neal D, Helleday T. Asim M, et al. Among authors: Rennie PS. Nat Commun. 2017 Aug 29;8(1):374. doi: 10.1038/s41467-017-00393-y. Nat Commun. 2017. PMID: 28851861 Free PMC article.
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.
Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN, Yang YC, Nyquist MD, Mostaghel E, Hsieh AC, Zhang X, Corey E, Brown LG, Nguyen HM, Pienta K, Ittmann M, Schweizer M, True LD, Wise D, Rennie PS, Vessella RL, Morrissey C, Nelson PS. Bluemn EG, et al. Among authors: Rennie PS. Cancer Cell. 2017 Oct 9;32(4):474-489.e6. doi: 10.1016/j.ccell.2017.09.003. Cancer Cell. 2017. PMID: 29017058 Free PMC article.
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.
Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F. Sheng X, et al. Among authors: Rennie PS. Nat Commun. 2019 Jan 24;10(1):323. doi: 10.1038/s41467-018-08152-3. Nat Commun. 2019. PMID: 30679434 Free PMC article.
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler R, Oo HZ, Tortora D, Clausen TM, Wang CK, Kumar G, Pereira MA, Ørum-Madsen MS, Agerbæk MØ, Gustavsson T, Nordmaj MA, Rich JR, Lallous N, Fazli L, Lee SS, Douglas J, Todenhöfer T, Esfandnia S, Battsogt D, Babcook JS, Al-Nakouzi N, Crabb SJ, Moskalev I, Kiss B, Davicioni E, Thalmann GN, Rennie PS, Black PC, Salanti A, Daugaard M. Seiler R, et al. Among authors: Rennie PS. Eur Urol. 2017 Jul;72(1):142-150. doi: 10.1016/j.eururo.2017.03.021. Epub 2017 Apr 10. Eur Urol. 2017. PMID: 28408175 Clinical Trial.
Oncolytic virotherapy for urological cancers.
Delwar Z, Zhang K, Rennie PS, Jia W. Delwar Z, et al. Among authors: Rennie PS. Nat Rev Urol. 2016 Jun;13(6):334-52. doi: 10.1038/nrurol.2016.84. Epub 2016 May 24. Nat Rev Urol. 2016. PMID: 27215429 Review.
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis.
Perletti G, Monti E, Marras E, Cleves A, Magri V, Trinchieri A, Rennie PS. Perletti G, et al. Among authors: Rennie PS. Arch Ital Urol Androl. 2015 Jul 7;87(2):121-9. doi: 10.4081/aiua.2015.2.121. Arch Ital Urol Androl. 2015. PMID: 26150028 Free article. Review.
Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
Tam KJ, Dalal K, Hsing M, Cheng CW, Khosravi S, Yenki P, Tse C, Peacock JW, Sharma A, Chiang YT, Wang Y, Cherkasov A, Rennie PS, Gleave ME, Ong CJ. Tam KJ, et al. Among authors: Rennie PS. Oncotarget. 2017 Feb 7;8(6):9617-9633. doi: 10.18632/oncotarget.14168. Oncotarget. 2017. PMID: 28038451 Free PMC article.
187 results
Jump to page